Hypomorphic homozygous mutations in phosphoglucomutase 3 (PGM3) impair immunity and increase serum IgE levels.

Archive ouverte

Sassi, Atfa | Lazaroski, Sandra | Wu, Gang | Haslam, Stuart M | Fliegauf, Manfred | Mellouli, Fethi | Patiroglu, Turkan | Unal, Ekrem | Ozdemir, Mehmet Akif | Jouhadi, Zineb | Khadir, Khadija | Ben-Khemis, Leila | Ben-Ali, Meriem | Ben-Mustapha, Imen | Borchani, Lamia | Pfeifer, Dietmar | Jakob, Thilo | Khemiri, Monia | Asplund, a Charlotta | Gustafsson, Manuela O | Lundin, Karin E | Falk-Sörqvist, Elin | Moens, Lotte N | Gungor, Hatice Eke | Engelhardt, Karin R | Dziadzio, Magdalena | Stauss, Hans | Fleckenstein, Bernhard | Meier, Rebecca | Prayitno, Khairunnadiya | Maul-Pavicic, Andrea | Schaffer, Sandra | Rakhmanov, Mirzokhid | Henneke, Philipp | Kraus, Helene | Eibel, Hermann | Kölsch, Uwe | Nadifi, Sellama | Nilsson, Mats | Bejaoui, Mohamed | Schäffer, Alejandro A | Smith, C I Edvard | Dell, Anne | Barbouche, Mohamed-Ridha | Grimbacher, Bodo

Edité par CCSD ; Elsevier -

International audience. BACKGROUND: Recurrent bacterial and fungal infections, eczema, and increased serum IgE levels characterize patients with the hyper-IgE syndrome (HIES). Known genetic causes for HIES are mutations in signal transducer and activator of transcription 3 (STAT3) and dedicator of cytokinesis 8 (DOCK8), which are involved in signal transduction pathways. However, glycosylation defects have not been described in patients with HIES. One crucial enzyme in the glycosylation pathway is phosphoglucomutase 3 (PGM3), which catalyzes a key step in the synthesis of uridine diphosphate N-acetylglucosamine, which is required for the biosynthesis of N-glycans. OBJECTIVE: We sought to elucidate the genetic cause in patients with HIES who do not carry mutations in STAT3 or DOCK8. METHODS: After establishing a linkage interval by means of SNPchip genotyping and homozygosity mapping in 2 families with HIES from Tunisia, mutational analysis was performed with selector-based, high-throughput sequencing. Protein expression was analyzed by means of Western blotting, and glycosylation was profiled by using mass spectrometry. RESULTS: Mutational analysis of candidate genes in an 11.9-Mb linkage region on chromosome 6 shared by 2 multiplex families identified 2 homozygous mutations in PGM3 that segregated with disease status and followed recessive inheritance. The mutations predict amino acid changes in PGM3 (p.Glu340del and p.Leu83Ser). A third homozygous mutation (p.Asp502Tyr) and the p.Leu83Ser variant were identified in 2 other affected families, respectively. These hypomorphic mutations have an effect on the biosynthetic reactions involving uridine diphosphate N-acetylglucosamine. Glycomic analysis revealed an aberrant glycosylation pattern in leukocytes demonstrated by a reduced level of tri-antennary and tetra-antennary N-glycans. T-cell proliferation and differentiation were impaired in patients. Most patients had developmental delay, and many had psychomotor retardation. CONCLUSION: Impairment of PGM3 function leads to a novel primary (inborn) error of development and immunity because biallelic hypomorphic mutations are associated with impaired glycosylation and a hyper-IgE-like phenotype.

Consulter en ligne

Suggestions

Du même auteur

The extended clinical phenotype of 64 patients with dedicator of cytokinesis 8 deficiency.

Archive ouverte | Engelhardt, Karin R | CCSD

International audience. Mutations in dedicator of cytokinesis 8 (DOCK8) cause a combined immunodeficiency (CID) also classified as autosomal recessive (AR) hyper-IgE syndrome (HIES). Recognizing patients with CID/HI...

Diagnostic challenge in a series of eleven patients with hyper IgE syndromes

Archive ouverte | Yaakoubi, Roukaya | CCSD

International audience. Hyper IgE syndromes (HIES) is a heterogeneous group of Inborn Errors of Immunity characterized by eczema, recurrent skin and lung infections associated with eosinophilia and elevated IgE leve...

Novel and recurrent AID mutations underlie prevalent autosomal recessive form of HIGM in consanguineous patients

Archive ouverte | Ouadani, Hanen | CCSD

International audience. no abstract

Chargement des enrichissements...